$DORM
Dorman Products, Inc.

2014 Q4 Form 10-Q Financial Statement

#000119312514391592 Filed on October 31, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $174.0M $197.8M $178.0M
YoY Change 2.46% 11.15% 13.77%
Cost Of Revenue $107.3M $121.9M $108.2M
YoY Change 3.47% 12.62% 11.98%
Gross Profit $66.70M $75.88M $69.70M
YoY Change 0.91% 8.86% 16.67%
Gross Profit Margin 38.34% 38.36% 39.17%
Selling, General & Admin $38.10M $37.41M $34.03M
YoY Change 10.43% 9.9% 18.94%
% of Gross Profit 57.12% 49.29% 48.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.700M $3.200M $2.700M
YoY Change 32.14% 18.52% 35.0%
% of Gross Profit 5.55% 4.22% 3.87%
Operating Expenses $38.10M $37.41M $34.03M
YoY Change 10.43% 9.9% 18.94%
Operating Profit $28.61M $38.48M $35.67M
YoY Change -9.48% 7.87% 14.58%
Interest Expense $0.00 $58.00K $47.00K
YoY Change 23.4% 23.68%
% of Operating Profit 0.0% 0.15% 0.13%
Other Income/Expense, Net
YoY Change
Pretax Income $28.60M $38.42M $35.62M
YoY Change -9.49% 7.85% 14.57%
Income Tax $9.900M $13.88M $12.74M
% Of Pretax Income 34.62% 36.13% 35.75%
Net Earnings $18.66M $24.54M $22.89M
YoY Change -9.52% 7.2% 12.51%
Net Earnings / Revenue 10.72% 12.4% 12.86%
Basic Earnings Per Share $0.68 $0.63
Diluted Earnings Per Share $0.52 $0.68 $0.62
COMMON SHARES
Basic Shares Outstanding 35.66M shares 35.90M shares 36.36M shares
Diluted Shares Outstanding 36.02M shares 36.63M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $47.70M $44.20M $48.30M
YoY Change -21.29% -8.49% -26.93%
Cash & Equivalents $47.66M $44.21M $48.34M
Short-Term Investments
Other Short-Term Assets $3.100M $24.70M $22.90M
YoY Change -88.39% 7.86% 2.23%
Inventory $173.5M $180.2M $149.1M
Prepaid Expenses
Receivables $206.0M $189.2M $178.7M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $430.4M $438.3M $399.0M
YoY Change 0.46% 9.83% 9.83%
LONG-TERM ASSETS
Property, Plant & Equipment $82.27M $80.97M $58.72M
YoY Change 26.99% 37.9% 23.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.65M $2.935M $1.734M
YoY Change 114.76% 69.26% 23.86%
Total Long-Term Assets $127.4M $113.9M $90.57M
YoY Change 26.39% 25.79% 20.11%
TOTAL ASSETS
Total Short-Term Assets $430.4M $438.3M $399.0M
Total Long-Term Assets $127.4M $113.9M $90.57M
Total Assets $557.7M $552.2M $489.6M
YoY Change 5.39% 12.78% 11.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.54M $53.96M $49.14M
YoY Change -2.8% 9.81% 26.97%
Accrued Expenses $20.58M $19.43M $20.61M
YoY Change 10.02% -5.72% 58.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $90.83M $82.30M $77.79M
YoY Change -0.99% 5.8% 50.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.822M $5.694M $5.779M
YoY Change -9.19% -1.47% 86.42%
Total Long-Term Liabilities $4.822M $5.694M $5.779M
YoY Change -9.19% -1.47% 86.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $90.83M $82.30M $77.79M
Total Long-Term Liabilities $4.822M $5.694M $5.779M
Total Liabilities $95.66M $88.00M $83.57M
YoY Change -1.44% 5.3% 26.05%
SHAREHOLDERS EQUITY
Retained Earnings $418.3M $401.7M $350.3M
YoY Change 13.0% 14.69%
Common Stock $43.77M $356.0K $365.0K
YoY Change 11891.51% -2.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $462.1M $445.7M $393.6M
YoY Change
Total Liabilities & Shareholders Equity $557.7M $552.2M $489.6M
YoY Change 5.39% 12.78% 11.6%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $18.66M $24.54M $22.89M
YoY Change -9.52% 7.2% 12.51%
Depreciation, Depletion And Amortization $3.700M $3.200M $2.700M
YoY Change 32.14% 18.52% 35.0%
Cash From Operating Activities $12.20M $28.20M $15.50M
YoY Change -50.81% 81.94% 198.08%
INVESTING ACTIVITIES
Capital Expenditures -$6.900M -$7.100M -$5.800M
YoY Change -41.53% 22.41% 18.37%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$6.900M -$7.100M -$5.800M
YoY Change -41.53% 22.41% 18.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.900M -30.90M -1.100M
YoY Change 171.43% 2709.09% -320.0%
NET CHANGE
Cash From Operating Activities 12.20M 28.20M 15.50M
Cash From Investing Activities -6.900M -7.100M -5.800M
Cash From Financing Activities -1.900M -30.90M -1.100M
Net Change In Cash 3.400M -9.800M 8.600M
YoY Change -72.36% -213.95% 975.0%
FREE CASH FLOW
Cash From Operating Activities $12.20M $28.20M $15.50M
Capital Expenditures -$6.900M -$7.100M -$5.800M
Free Cash Flow $19.10M $35.30M $21.30M
YoY Change -47.81% 65.73% 110.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36464958 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36464958 shares
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27708000
CY2013Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1800000
CY2013Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
1900000
CY2013Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
3700000
CY2013Q2 dorm Goodwill And Other Intangible Assets Acquired
GoodwillAndOtherIntangibleAssetsAcquired
3600000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43119000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11779000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60593000
CY2013Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
63550000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64786000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5851000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
109459 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
141500 shares
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91738000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
365000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
97742000
CY2013Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
3129000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
61255000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
370157000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
18480000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18704000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
413641000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5310000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
529169000
CY2013Q4 us-gaap Assets
Assets
529169000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
20798000
CY2013Q4 us-gaap Inventory Net
InventoryNet
164421000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
180777000
CY2013Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
30089000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1854000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
432440000
CY2013Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
65879000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.47
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.13
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
267800000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48335000
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35670143 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35670143 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.25
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.28
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
65000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.49
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2233420
CY2014Q3 us-gaap Assets
Assets
552186000
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
21258000
CY2014Q3 us-gaap Inventory Net
InventoryNet
180155000
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
189220000
CY2014Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
30014000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
93458 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1708827 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
75000 shares
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
82301000
CY2014Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
800000
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
356000
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
53955000
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
401724000
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
18506000
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19429000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
445685000
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5694000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
552186000
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43605000
CY2014Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1100000
CY2014Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
200000
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8917000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44210000
CY2014Q3 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
61072000
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80972000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2518020
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3422000
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
116364000
CY2014Q3 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
2719000
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2935000
CY2014Q3 us-gaap Assets Current
AssetsCurrent
438265000
CY2014Q3 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
88005000
CY2014Q3 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
328300000
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35664573 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.67
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
267000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
36841000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36610000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36343000 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12949000
us-gaap Net Income Loss
NetIncomeLoss
61301000
us-gaap Interest Paid
InterestPaid
150000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
38623000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
236000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7417000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
7668000
us-gaap Interest Expense
InterestExpense
148000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
98551000
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
1897000
us-gaap Gross Profit
GrossProfit
194883000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
31325000
us-gaap Sales Revenue Net
SalesRevenueNet
494657000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
799000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3722000
us-gaap Operating Income Loss
OperatingIncomeLoss
96332000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
96184000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
101000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20627000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34883000
us-gaap Restricted Stock Expense
RestrictedStockExpense
700000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
299774000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1368000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-14846000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
503000
us-gaap Share Based Compensation
ShareBasedCompensation
769000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
2493000
us-gaap Proceeds From Sale Of Other Receivables
ProceedsFromSaleOfOtherReceivables
296500000
dorm Other Stock Related Activity
OtherStockRelatedActivity
793000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
2664000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
5348 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.97
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
Dorman Products, Inc.
dei Trading Symbol
TradingSymbol
DORM
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
35.43
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
38100 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
155000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
47406000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
52.37
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
32000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
21347 shares
dei Document Period End Date
DocumentPeriodEndDate
2014-09-27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
24.33
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-27
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36372000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.97
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M
dei Entity Central Index Key
EntityCentralIndexKey
0000868780
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Business Acquisition Effective Date Of Acquisition1
BusinessAcquisitionEffectiveDateOfAcquisition1
2013-05-17
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-12-31
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
66500 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36217000 shares
us-gaap Gross Profit
GrossProfit
220484000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
38192000
us-gaap Sales Revenue Net
SalesRevenueNet
577495000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1878000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15734000
us-gaap Operating Income Loss
OperatingIncomeLoss
112123000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
111963000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22992000
us-gaap Net Income Loss
NetIncomeLoss
71331000
us-gaap Interest Paid
InterestPaid
176000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8662000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-434000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9001000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1221000
us-gaap Interest Expense
InterestExpense
160000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
108361000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
219000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-16383000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40632000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500000
us-gaap Restricted Stock Expense
RestrictedStockExpense
1500000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
357011000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-40797000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-22992000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
463000
us-gaap Share Based Compensation
ShareBasedCompensation
1510000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-9168000
us-gaap Proceeds From Sale Of Other Receivables
ProceedsFromSaleOfOtherReceivables
380200000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2100000
dorm Other Stock Related Activity
OtherStockRelatedActivity
81000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
dorm Maximum Grant Period From Date Of Plan Approval
MaximumGrantPeriodFromDateOfPlanApproval
P10Y
dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
54.02
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
41341000
dorm Date Of Plan Approval
DateOfPlanApproval
2009-05-20
CY2013 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
78580 shares
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500000
CY2013 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
44.39
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
270000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36632000 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36362000 shares
CY2013Q3 us-gaap Gross Profit
GrossProfit
69704000
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
177953000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
35670000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
35623000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
22887000
CY2013Q3 us-gaap Interest Expense
InterestExpense
47000
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34034000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12736000
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
108249000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
126000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36024000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35898000 shares
CY2014Q3 us-gaap Gross Profit
GrossProfit
75881000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
197796000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
38476000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
38418000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
24536000
CY2014Q3 us-gaap Interest Expense
InterestExpense
58000
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37405000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13882000
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
121915000

Files In Submission

Name View Source Status
0001193125-14-391592-index-headers.html Edgar Link pending
0001193125-14-391592-index.html Edgar Link pending
0001193125-14-391592.txt Edgar Link pending
0001193125-14-391592-xbrl.zip Edgar Link pending
d790281d10q.htm Edgar Link pending
d790281dex311.htm Edgar Link pending
d790281dex312.htm Edgar Link pending
d790281dex32.htm Edgar Link pending
dorm-20140927.xml Edgar Link completed
dorm-20140927.xsd Edgar Link pending
dorm-20140927_cal.xml Edgar Link unprocessable
dorm-20140927_def.xml Edgar Link unprocessable
dorm-20140927_lab.xml Edgar Link unprocessable
dorm-20140927_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending